Neda Fatima1*, Juveriya Israr1,2, Shabroz Alam1, Hira Moid1,3

STRUCTURE-BASED DRUG DESIGN FOR PARKINSON'S DISEASE: MOLECULAR DOCKING ANALYSIS OF NOVEL COMPOUNDS

Parkinson's disease is a progressive neurodegenerative condition characterized by dopaminergic neuron destruction and misfolded proteins. Current treatments focus on motor symptoms, but do not target neuronal degeneration. Recent studies suggest a connection between lipid metabol...

STRUCTURE-BASED DRUG DESIGN FOR PARKINSON'S DISEASE: MOLECULAR DOCKING ANALYSIS OF NOVEL COMPOUNDS

Parkinson's disease is a progressive neurodegenerative condition characterized by dopaminergic neuron destruction and misfolded proteins. Current treatments focus on motor symptoms, but do not target neuronal degeneration. Recent studies suggest a connection between lipid metabol...